Tag Archives: Dr Reddy’s

India: Varenacline Patent revoked

Varenaciline is marketed by Pfizer world wide as Chandix or Champix. Varenaciline is marketed as tartarate salt form, this salt form is protected by US patent 6890927 and its indian equivalent is 204091 (863/MUMNP/2003). This ‘091 patent is opposed by Dr … Continue reading

Posted in Patent case | Tagged , , , , , | Leave a comment

CI & Patent News: 24/11/2010

1) GlaxoSmithKline and Dr. Reddy’s Agree to the Sale of US Penicillin Facility and Products (Link) … Under the agreement, GSK will transfer ownership of its penicillin manufacturing site in Bristol, Tennessee, United States, and rights for the Augmentin® and … Continue reading

Posted in Daily interesting IP news | Tagged , , , , , , | Leave a comment